Rock Steady Boxing is a health and wellness program designed for people with Parkinson's disease, a neurological condition that affects balance, strength, walking, and especially confidence. It's based on the...

Alora Pharmaceuticals, LLC, is pleased to announce that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through bankruptcy proceedings, substantially all of Monarch PCM, LLC's manufacturing capabilities located in...

The World Health Organization (WHO) and the International Menopause Society designates October as World Menopause Month. In recognition of October as World Menopause Awareness Month, Avion Pharmaceuticals encourages our women’s...

PM360, a leading life sciences marketing industry trade publication, announced the winners of their 14th annual Trailblazer Awards during an event held at Gotham Hall in New York City on Thursday, September 22, 2022....

Alora Pharmaceuticals, LLC a specialty pharmaceutical company based in Alpharetta, GA is pleased to announce that Shannon Faught, Chief Commercial Officer for Alora’s branded pharmaceutical business has been recognized as...

PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device industries. Published monthly, PM360 is the only journal that focuses on delivering...

Pharmaceutical Executive Miguel Gomez will lead Alora Pharmaceutical Global Quality strategies Alora Pharmaceuticals, announced today that Miguel Gomez, has been appointed Chief Quality Officer. With his appointment, Alora Pharmaceuticals, LLC...

Celebrating ambitious pioneers tackling our biggest challenges Ernst & Young LLP (EY US) has announced that Harold “Art” Deas, of Alora Pharmaceuticals was named an Entrepreneur Of The Year® 2022...

Pharmaceutical Executive Shannon Faught will lead Alora Pharmaceutical commercial strategies Alora Pharmaceuticals, announced today that Shannon Faught has been appointed Chief Commercial Officer. In this role, Ms. Faught will lead...

Parkinson's Disease Treatment is the First and Only Carbidopa/Levodopa (CD/LD) TabletDesigned to be Divided for Precise Dosing Avion Pharmaceuticals, LLC, an Alora Pharmaceuticals company, announced the commercial launch of DHIVY,...

Alora Pharmaceuticals’ Subsidiaries Awarded Top Small Employer for Fourth Consecutive Year Alora Pharmaceuticals today announced its subsidiaries Avion Pharmaceuticals, LLC and Acella Pharmaceuticals, LLC earned the top spot for small...

Starting 2021 on some very exciting news!! Avion has been awarded “The Most Innovative Women’s health Pharmaceutical Company in USA” by Global Health & Pharma (GHP) and the official press...

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, and affiliate company Acella Pharmaceuticals, LLC, have earned back-to-back annual recognition as the "Best Place to Work in Medical Sales: Small Pharma Category."...

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, has announced a license and commercialization agreement with Aspen Pharma USA Inc. and Aspen Global Incorporated, both wholly owned subsidiaries of Aspen Pharmacare...

As a valued member of the Avion Pharmaceuticals’ community, nothing is more important to us than your health and safety. As the spread of coronavirus, known as COVID-19, continues to...

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announces it received the 2020 “Best Place to Work in Medical Sales: Small Pharma Category” award from MedReps, the leading job site for...

Avion Pharmaceuticals, LLC., a women’s health pharmaceutical company, is partnering with Miesha Tate, a former UFC and MMA champion, to bring greater awareness to the importance of prenatal care and...

Alora Pharmaceuticals, LLC, parent company of Avion Pharmaceuticals, LLC, and Acella Pharmaceuticals, LLC, announced the relocation of the corporate headquarters of its two companies to a new 58,000 sq. ft....

Avion Pharmaceuticals, LLC, the makers of the Prenate® line of prescription prenatal vitamins, received approval of its new drug application (NDA) for the oral contraceptive Balcoltra™ (levonorgestrel and ethinyl estradiol...

Avion Pharmaceuticals, a specialty pharmaceutical company providing innovative pharmaceutical and dietary supplement products, focused on women’s health and dermatology, recognizes the important role prenatal vitamins play in a healthy pregnancy....

In its continuing effort to illustrate the enhanced benefits of Avion’s Prenate® line of prenatal dietary supplements, Avion pharmaceuticals, LLC, recently relaunched its product-based website, www.prenate.com. The relaunch was designed...

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company and maker of Prenate® prescription prenatal vitamins, recently announced it has solidified its continuing partnership with Gnosis S.P.A. to provide Quatrefolic®, the fourth-generation...

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to support the United States Breastfeeding Committee’s (USBC) designation of August as National Breastfeeding Month. Avion applauds the efforts of the...

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, recently announced it will be exhibiting at the American College of Obstetricians and Gynecologists (ACOG), Women’s Healthcare Physician’s 2016 Annual Clinical and Scientific...

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, is pleased to announce the appointment of Harold A. Deas, Jr. as Chief Executive Officer. Mr. Deas, who will retain his role as...

The National Birth Defects Prevention Network (NBDPN) and the U.S. Centers for Disease Control and Prevention (CDC) have invited women and their families to make a PACT for birth defects...

Avion Pharmaceuticals was nominated and awarded a prestigious Healthcare Distribution Management Association (HDMA) 2014 Diana Award for the Best Manufacturer of the Year Award under $300MM. This is a highly...

Avion Pharmaceuticals, a specialty pharmaceutical company, is pleased to announce their business partnership with Utah based Albion® Laboratories. This collaboration will focus on the licensing of unique, patented API ingredients...

Avion Pharmaceuticals, a specialty pharmaceutical company, announces the promotion of Mike Sullivan to the position of President. Mike joined Avion Pharmaceuticals in 2011 as Vice President of Sales and Marketing....

Avion Pharmaceuticals, a specialty pharmaceutical company, recently announced the launch of two advanced vitamin formulations as the newest additions to the Prenate® Vitamin Family. Prenate® Enhance and Prenate® Restore have...

Avion Pharmaceuticals, a specialty pharmaceutical company, announced its recent transaction with Shawnee, Kan.-based Nephro-Tech 1, LLC, to license and market Formical® (calcium formate) on a semi-exclusive basis as part of...

Avion Pharmaceuticals, a specialty pharmaceutical company, participated as an exhibitor at the annual Nurse Practitioners in Women’s Health Annual Meeting, held September 26-28th at the Hilton Bayfront in San Diego,...

Avion Pharmaceuticals, a specialty pharmaceutical company, is pleased to announce their recent participation in the American College of Nurse Midwives (ACNM ) Annual Meeting in Nashville, Tennessee from May 29th...

Avion Pharmaceuticals, a specialty pharmaceutical company, announces the launch of Prenate® Chewable, a chewable prescription prenatal vitamin with a delicious chocolate flavor. For Avion Pharmaceuticals, the launch of Prenate® Chewable...

Avion Pharmaceuticals, a specialty pharmaceutical company, announces their participation as an exhibitor at the annual American Academy of Dermatology Meeting. The meeting was held at the Miami Beach Convention Center...

Avion Pharmaceuticals, a specialty pharmaceutical company, announces their participation as an exhibitor at the annual meeting of the South Atlantic Association of Obstetrics and Gynecologists (SAAOG). The meeting was held...

Avion Pharmaceuticals, a specialty pharmaceutical company, announces their participation as an exhibitor at the annual Nurse Practitioner in Women’s Health Meeting. The meeting is planned for October 10-13th, 2012 at...